

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alpha-linolenic acid metabolic process (GO:0036109) | 4.06177659 |
| 2 | protein retention in ER lumen (GO:0006621) | 3.99808627 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.98570277 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.98570277 |
| 5 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.87441328 |
| 6 | protein localization to endosome (GO:0036010) | 3.80189648 |
| 7 | positive regulation of histone deacetylation (GO:0031065) | 3.75827508 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.75014560 |
| 9 | Golgi transport vesicle coating (GO:0048200) | 3.66783365 |
| 10 | COPI coating of Golgi vesicle (GO:0048205) | 3.66783365 |
| 11 | regulation of cholesterol homeostasis (GO:2000188) | 3.59979320 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.59414189 |
| 13 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.56161896 |
| 14 | negative regulation of cell size (GO:0045792) | 3.48182013 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.47456563 |
| 16 | pinocytosis (GO:0006907) | 3.46561786 |
| 17 | valine metabolic process (GO:0006573) | 3.32944187 |
| 18 | response to laminar fluid shear stress (GO:0034616) | 3.31903125 |
| 19 | 2-oxoglutarate metabolic process (GO:0006103) | 3.31375688 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 3.29333466 |
| 21 | sodium ion export (GO:0071436) | 3.27798328 |
| 22 | barbed-end actin filament capping (GO:0051016) | 3.26194401 |
| 23 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.25758519 |
| 24 | embryonic process involved in female pregnancy (GO:0060136) | 3.16211353 |
| 25 | tricarboxylic acid metabolic process (GO:0072350) | 3.12630531 |
| 26 | proline biosynthetic process (GO:0006561) | 3.12394474 |
| 27 | regulation of ARF protein signal transduction (GO:0032012) | 3.08855444 |
| 28 | macroautophagy (GO:0016236) | 3.04911408 |
| 29 | lysine catabolic process (GO:0006554) | 3.01993177 |
| 30 | lysine metabolic process (GO:0006553) | 3.01993177 |
| 31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.01679373 |
| 32 | negative regulation of cell killing (GO:0031342) | 3.01679373 |
| 33 | basement membrane organization (GO:0071711) | 3.01469853 |
| 34 | regulation of extracellular matrix disassembly (GO:0010715) | 3.01422960 |
| 35 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.99366720 |
| 36 | mannose metabolic process (GO:0006013) | 2.99312986 |
| 37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.98696685 |
| 38 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.97964217 |
| 39 | regulation of ARF GTPase activity (GO:0032312) | 2.97935095 |
| 40 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.97867543 |
| 41 | focal adhesion assembly (GO:0048041) | 2.96196477 |
| 42 | cell-substrate adherens junction assembly (GO:0007045) | 2.96196477 |
| 43 | glucose 6-phosphate metabolic process (GO:0051156) | 2.95930837 |
| 44 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.91743243 |
| 45 | adherens junction assembly (GO:0034333) | 2.90787878 |
| 46 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.89929922 |
| 47 | peptidyl-lysine dimethylation (GO:0018027) | 2.85414708 |
| 48 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.85001767 |
| 49 | response to muramyl dipeptide (GO:0032495) | 2.83782379 |
| 50 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.83700696 |
| 51 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.83625836 |
| 52 | regulation of cholesterol storage (GO:0010885) | 2.82830364 |
| 53 | positive regulation of nuclease activity (GO:0032075) | 2.77665176 |
| 54 | growth hormone receptor signaling pathway (GO:0060396) | 2.77458353 |
| 55 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.77097509 |
| 56 | synaptic vesicle maturation (GO:0016188) | 2.76420349 |
| 57 | pentose-phosphate shunt (GO:0006098) | 2.76115387 |
| 58 | negative regulation of lipid transport (GO:0032369) | 2.75375910 |
| 59 | cell-substrate junction assembly (GO:0007044) | 2.75156044 |
| 60 | protein-lipid complex assembly (GO:0065005) | 2.74642874 |
| 61 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.73107973 |
| 62 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.73042437 |
| 63 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.71277872 |
| 64 | cerebellar Purkinje cell layer development (GO:0021680) | 2.69971547 |
| 65 | sexual reproduction (GO:0019953) | 2.69654853 |
| 66 | modulation by symbiont of host cellular process (GO:0044068) | 2.68644184 |
| 67 | regulation of fatty acid oxidation (GO:0046320) | 2.67572634 |
| 68 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.65533105 |
| 69 | plasma lipoprotein particle assembly (GO:0034377) | 2.64246963 |
| 70 | oxaloacetate metabolic process (GO:0006107) | 2.62961166 |
| 71 | skin morphogenesis (GO:0043589) | 2.62706343 |
| 72 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.60336352 |
| 73 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.60208240 |
| 74 | stress fiber assembly (GO:0043149) | 2.58314355 |
| 75 | 4-hydroxyproline metabolic process (GO:0019471) | 2.58046484 |
| 76 | hypotonic response (GO:0006971) | 2.57675709 |
| 77 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.57346206 |
| 78 | low-density lipoprotein particle clearance (GO:0034383) | 2.56451451 |
| 79 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.56195904 |
| 80 | positive regulation of protein deacetylation (GO:0090312) | 2.55096885 |
| 81 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.54822576 |
| 82 | negative regulation of fibrinolysis (GO:0051918) | 2.54578063 |
| 83 | apoptotic cell clearance (GO:0043277) | 2.53535435 |
| 84 | positive thymic T cell selection (GO:0045059) | 2.52320183 |
| 85 | peptidyl-proline hydroxylation (GO:0019511) | 2.51701917 |
| 86 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.51690978 |
| 87 | maternal placenta development (GO:0001893) | 2.51354654 |
| 88 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.51059937 |
| 89 | plasma membrane repair (GO:0001778) | 2.49242435 |
| 90 | positive regulation of extracellular matrix organization (GO:1903055) | 2.49204998 |
| 91 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.49128620 |
| 92 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.48810460 |
| 93 | carnitine shuttle (GO:0006853) | 2.48180404 |
| 94 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.46969362 |
| 95 | cellular modified amino acid catabolic process (GO:0042219) | 2.46859191 |
| 96 | activation of protein kinase A activity (GO:0034199) | 2.46815599 |
| 97 | fatty acid transmembrane transport (GO:1902001) | 2.46527753 |
| 98 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.46500920 |
| 99 | glucose catabolic process (GO:0006007) | 2.46108999 |
| 100 | natural killer cell differentiation (GO:0001779) | 2.45539821 |
| 101 | histone H3-K36 demethylation (GO:0070544) | 2.45476713 |
| 102 | regulation of extracellular matrix organization (GO:1903053) | 2.44767435 |
| 103 | vesicle coating (GO:0006901) | 2.44681865 |
| 104 | regulation of nuclease activity (GO:0032069) | 2.44601953 |
| 105 | negative regulation of cholesterol transport (GO:0032375) | 2.43722624 |
| 106 | negative regulation of sterol transport (GO:0032372) | 2.43722624 |
| 107 | proline metabolic process (GO:0006560) | 2.43015830 |
| 108 | positive regulation of lipid catabolic process (GO:0050996) | 2.42568553 |
| 109 | cellular response to growth hormone stimulus (GO:0071378) | 2.42235985 |
| 110 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.41687628 |
| 111 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.41687628 |
| 112 | modulation by symbiont of host immune response (GO:0052553) | 2.41687628 |
| 113 | positive regulation by symbiont of host defense response (GO:0052509) | 2.41687628 |
| 114 | modulation by symbiont of host defense response (GO:0052031) | 2.41687628 |
| 115 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.41687628 |
| 116 | urea metabolic process (GO:0019627) | 2.41176192 |
| 117 | urea cycle (GO:0000050) | 2.41176192 |
| 118 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.40814651 |
| 119 | regulation of lipid catabolic process (GO:0050994) | 2.40286032 |
| 120 | protein hydroxylation (GO:0018126) | 2.39520526 |
| 121 | cell communication by electrical coupling (GO:0010644) | 2.39071997 |
| 122 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.38944095 |
| 123 | NADPH regeneration (GO:0006740) | 2.38882780 |
| 124 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.38451550 |
| 125 | regulation of response to osmotic stress (GO:0047484) | 2.38430750 |
| 126 | L-phenylalanine metabolic process (GO:0006558) | 2.38214851 |
| 127 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.38214851 |
| 128 | kynurenine metabolic process (GO:0070189) | 2.37374646 |
| 129 | cell adhesion mediated by integrin (GO:0033627) | 2.37358000 |
| 130 | apoptotic process involved in morphogenesis (GO:0060561) | 2.37263450 |
| 131 | negative regulation of necroptotic process (GO:0060546) | 2.35874155 |
| 132 | aspartate family amino acid catabolic process (GO:0009068) | 2.35446333 |
| 133 | retrograde transport, endosome to Golgi (GO:0042147) | 2.34949833 |
| 134 | ER-nucleus signaling pathway (GO:0006984) | 2.34435434 |
| 135 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.34176048 |
| 136 | locomotory exploration behavior (GO:0035641) | 2.33733655 |
| 137 | negative regulation of fatty acid transport (GO:2000192) | 2.33531445 |
| 138 | response to peptidoglycan (GO:0032494) | 2.33455116 |
| 139 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.32786978 |
| 140 | L-phenylalanine catabolic process (GO:0006559) | 2.32786978 |
| 141 | COPII vesicle coating (GO:0048208) | 2.32502677 |
| 142 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.31789123 |
| 143 | regulation of apoptotic cell clearance (GO:2000425) | 2.31505687 |
| 144 | dosage compensation (GO:0007549) | 2.31371621 |
| 145 | receptor catabolic process (GO:0032801) | 2.31284121 |
| 146 | modulation by virus of host process (GO:0019054) | 2.31158449 |
| 147 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.29579035 |
| 148 | cortical actin cytoskeleton organization (GO:0030866) | 2.29471376 |
| 149 | cellular response to unfolded protein (GO:0034620) | 2.29151894 |
| 150 | layer formation in cerebral cortex (GO:0021819) | 2.28998176 |
| 151 | cellular hyperosmotic response (GO:0071474) | 2.28450049 |
| 152 | regulation of early endosome to late endosome transport (GO:2000641) | 2.28277586 |
| 153 | glutamate metabolic process (GO:0006536) | 2.28268778 |
| 154 | regulation of translational termination (GO:0006449) | 2.28096618 |
| 155 | regulation of defense response to virus by virus (GO:0050690) | 2.27625746 |
| 156 | sulfur amino acid catabolic process (GO:0000098) | 2.26189350 |
| 157 | alanine transport (GO:0032328) | 2.25764144 |
| 158 | regulation of triglyceride catabolic process (GO:0010896) | 2.25726508 |
| 159 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.25608606 |
| 160 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.25478221 |
| 161 | cell-cell junction maintenance (GO:0045217) | 2.24853276 |
| 162 | positive regulation of phagocytosis (GO:0050766) | 2.24477104 |
| 163 | activation of Rac GTPase activity (GO:0032863) | 2.23511015 |
| 164 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.22473653 |
| 165 | histone H4 deacetylation (GO:0070933) | 2.20873078 |
| 166 | modulation by virus of host morphology or physiology (GO:0019048) | 2.20543512 |
| 167 | glycolytic process (GO:0006096) | 2.18967714 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.82001519 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.25513168 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.00707481 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.75147624 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.74908985 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 2.74348676 |
| 7 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.65349361 |
| 8 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.44562867 |
| 9 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.38910785 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.37567955 |
| 11 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.29763655 |
| 12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.28783261 |
| 13 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.22628574 |
| 14 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.22588782 |
| 15 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.16508125 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.13322505 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.12000354 |
| 18 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.07830709 |
| 19 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.99057982 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.95135471 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.93142484 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.89860326 |
| 23 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.85632068 |
| 24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81886888 |
| 25 | UTX_26944678_Chip-Seq_JUKART_Human | 1.79991883 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.76331085 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75860900 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 1.75316589 |
| 29 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.71198276 |
| 30 | KDM2B_26808549_Chip-Seq_K562_Human | 1.67784167 |
| 31 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.65939548 |
| 32 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.65761798 |
| 33 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.63144023 |
| 34 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.63123071 |
| 35 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.62648524 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.61201980 |
| 37 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.61162538 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.59872954 |
| 39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58091975 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.56415917 |
| 41 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.55896568 |
| 42 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.55863251 |
| 43 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.49398968 |
| 44 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.49229194 |
| 45 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.46969376 |
| 46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45609899 |
| 47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.44486908 |
| 48 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.44408593 |
| 49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.43880111 |
| 50 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43489957 |
| 51 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.39882531 |
| 52 | GATA1_19941826_ChIP-Seq_K562_Human | 1.39095896 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38986572 |
| 54 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.38714644 |
| 55 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.37694080 |
| 56 | * P68_20966046_ChIP-Seq_HELA_Human | 1.36698320 |
| 57 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.36104214 |
| 58 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34211261 |
| 59 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.34065652 |
| 60 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33189777 |
| 61 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.32922731 |
| 62 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.32074598 |
| 63 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.31936094 |
| 64 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30641231 |
| 65 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.29538145 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.29186342 |
| 67 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.27836695 |
| 68 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.26940917 |
| 69 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.26785358 |
| 70 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.26757654 |
| 71 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25408691 |
| 72 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.24860222 |
| 73 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.24327104 |
| 74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24326986 |
| 75 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23899957 |
| 76 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.21078539 |
| 77 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.20757027 |
| 78 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20497694 |
| 79 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.20104103 |
| 80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20052241 |
| 81 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.19077160 |
| 82 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.19073891 |
| 83 | MAF_26560356_Chip-Seq_TH2_Human | 1.18942182 |
| 84 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.18745382 |
| 85 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17914689 |
| 86 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.17792046 |
| 87 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.17792046 |
| 88 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.17563761 |
| 89 | * MYB_26560356_Chip-Seq_TH2_Human | 1.16636711 |
| 90 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16413965 |
| 91 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.15866192 |
| 92 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.15123697 |
| 93 | ATF3_27146783_Chip-Seq_COLON_Human | 1.14901694 |
| 94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13671436 |
| 95 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12659414 |
| 96 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.12580932 |
| 97 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.12093973 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11441522 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10860705 |
| 100 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10780788 |
| 101 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.10652905 |
| 102 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10595535 |
| 103 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.10448962 |
| 104 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10376134 |
| 105 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09938124 |
| 106 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.09662644 |
| 107 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08750321 |
| 108 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.08723469 |
| 109 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08251876 |
| 110 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.07361094 |
| 111 | MYB_26560356_Chip-Seq_TH1_Human | 1.07108498 |
| 112 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.05951087 |
| 113 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.05424891 |
| 114 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05111306 |
| 115 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.03903390 |
| 116 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03725878 |
| 117 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.03716733 |
| 118 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03099052 |
| 119 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03096735 |
| 120 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.02257517 |
| 121 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.99700397 |
| 122 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.99685068 |
| 123 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98461520 |
| 124 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.98396606 |
| 125 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97360895 |
| 126 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.96704097 |
| 127 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.95998953 |
| 128 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95752243 |
| 129 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95615473 |
| 130 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.95022543 |
| 131 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.94712744 |
| 132 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.93964600 |
| 133 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.93648991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 3.86824734 |
| 2 | MP0008260_abnormal_autophagy | 3.50543118 |
| 3 | MP0009840_abnormal_foam_cell | 3.30501393 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.18095981 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.12514612 |
| 6 | MP0003300_gastrointestinal_ulcer | 3.05735425 |
| 7 | MP0004130_abnormal_muscle_cell | 2.57758023 |
| 8 | MP0005365_abnormal_bile_salt | 2.47396741 |
| 9 | MP0005360_urolithiasis | 2.39425226 |
| 10 | MP0003303_peritoneal_inflammation | 2.27479328 |
| 11 | MP0005083_abnormal_biliary_tract | 2.26340490 |
| 12 | MP0002909_abnormal_adrenal_gland | 2.22983337 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.21585020 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.16202319 |
| 15 | MP0008961_abnormal_basal_metabolism | 2.13538171 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.04910928 |
| 17 | MP0004510_myositis | 2.04025641 |
| 18 | MP0003252_abnormal_bile_duct | 2.01675776 |
| 19 | MP0004272_abnormal_basement_membrane | 1.83306043 |
| 20 | MP0004859_abnormal_synaptic_plasticity | 1.82567377 |
| 21 | MP0003329_amyloid_beta_deposits | 1.82347361 |
| 22 | MP0005085_abnormal_gallbladder_physiolo | 1.81317120 |
| 23 | MP0003172_abnormal_lysosome_physiology | 1.78138534 |
| 24 | MP0010234_abnormal_vibrissa_follicle | 1.77477527 |
| 25 | MP0000685_abnormal_immune_system | 1.72523946 |
| 26 | MP0005257_abnormal_intraocular_pressure | 1.70926886 |
| 27 | MP0004858_abnormal_nervous_system | 1.67805922 |
| 28 | MP0000858_altered_metastatic_potential | 1.63330391 |
| 29 | MP0000604_amyloidosis | 1.62829658 |
| 30 | MP0000013_abnormal_adipose_tissue | 1.62073166 |
| 31 | MP0004233_abnormal_muscle_weight | 1.62052828 |
| 32 | MP0009278_abnormal_bone_marrow | 1.59052134 |
| 33 | MP0001915_intracranial_hemorrhage | 1.58761085 |
| 34 | MP0000609_abnormal_liver_physiology | 1.58309608 |
| 35 | MP0003221_abnormal_cardiomyocyte_apopto | 1.57436353 |
| 36 | MP0005409_darkened_coat_color | 1.55976797 |
| 37 | MP0004947_skin_inflammation | 1.52477795 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.48226434 |
| 39 | MP0002837_dystrophic_cardiac_calcinosis | 1.44174019 |
| 40 | MP0005076_abnormal_cell_differentiation | 1.43714269 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.43467750 |
| 42 | MP0002118_abnormal_lipid_homeostasis | 1.37914901 |
| 43 | MP0005375_adipose_tissue_phenotype | 1.37246831 |
| 44 | MP0000003_abnormal_adipose_tissue | 1.36609463 |
| 45 | MP0005666_abnormal_adipose_tissue | 1.35200765 |
| 46 | MP0003075_altered_response_to | 1.34328712 |
| 47 | MP0002877_abnormal_melanocyte_morpholog | 1.33928721 |
| 48 | MP0003724_increased_susceptibility_to | 1.30279154 |
| 49 | MP0003453_abnormal_keratinocyte_physiol | 1.29417420 |
| 50 | MP0000751_myopathy | 1.28713834 |
| 51 | MP0001666_abnormal_nutrient_absorption | 1.28213458 |
| 52 | MP0005023_abnormal_wound_healing | 1.28144386 |
| 53 | MP0000747_muscle_weakness | 1.26760233 |
| 54 | MP0003828_pulmonary_edema | 1.21793960 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.21176138 |
| 56 | MP0003436_decreased_susceptibility_to | 1.20902643 |
| 57 | MP0001348_abnormal_lacrimal_gland | 1.20484729 |
| 58 | MP0003045_fibrosis | 1.18708164 |
| 59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.16989779 |
| 60 | MP0002269_muscular_atrophy | 1.16844881 |
| 61 | MP0004087_abnormal_muscle_fiber | 1.16188278 |
| 62 | MP0000767_abnormal_smooth_muscle | 1.16107486 |
| 63 | MP0003122_maternal_imprinting | 1.15232913 |
| 64 | MP0005670_abnormal_white_adipose | 1.13808616 |
| 65 | MP0003183_abnormal_peptide_metabolism | 1.12164993 |
| 66 | MP0001849_ear_inflammation | 1.11737806 |
| 67 | MP0005319_abnormal_enzyme/_coenzyme | 1.07935467 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 1.06609357 |
| 69 | MP0008438_abnormal_cutaneous_collagen | 1.04338133 |
| 70 | MP0005332_abnormal_amino_acid | 1.03482275 |
| 71 | MP0006054_spinal_hemorrhage | 1.01450801 |
| 72 | MP0005621_abnormal_cell_physiology | 1.01344166 |
| 73 | MP0002060_abnormal_skin_morphology | 1.00652039 |
| 74 | MP0004264_abnormal_extraembryonic_tissu | 1.00513966 |
| 75 | MP0000569_abnormal_digit_pigmentation | 1.00064128 |
| 76 | MP0003566_abnormal_cell_adhesion | 0.98654317 |
| 77 | MP0003279_aneurysm | 0.97459069 |
| 78 | MP0003763_abnormal_thymus_physiology | 0.97384915 |
| 79 | MP0008875_abnormal_xenobiotic_pharmacok | 0.97100572 |
| 80 | MP0001835_abnormal_antigen_presentation | 0.96965470 |
| 81 | MP0003195_calcinosis | 0.96614825 |
| 82 | MP0005397_hematopoietic_system_phenotyp | 0.96433694 |
| 83 | MP0001545_abnormal_hematopoietic_system | 0.96433694 |
| 84 | MP0002166_altered_tumor_susceptibility | 0.96277982 |
| 85 | MP0002078_abnormal_glucose_homeostasis | 0.94295162 |
| 86 | MP0010352_gastrointestinal_tract_polyps | 0.93543070 |
| 87 | MP0006082_CNS_inflammation | 0.93520716 |
| 88 | MP0005387_immune_system_phenotype | 0.92341718 |
| 89 | MP0001790_abnormal_immune_system | 0.92341718 |
| 90 | MP0009780_abnormal_chondrocyte_physiolo | 0.91163761 |
| 91 | MP0001958_emphysema | 0.90730463 |
| 92 | MP0000598_abnormal_liver_morphology | 0.90293179 |
| 93 | MP0003091_abnormal_cell_migration | 0.89418917 |
| 94 | MP0001730_embryonic_growth_arrest | 0.88004611 |
| 95 | MP0009384_cardiac_valve_regurgitation | 0.87810788 |
| 96 | MP0001853_heart_inflammation | 0.87146163 |
| 97 | MP0000759_abnormal_skeletal_muscle | 0.86931341 |
| 98 | MP0009643_abnormal_urine_homeostasis | 0.86907430 |
| 99 | MP0001800_abnormal_humoral_immune | 0.86645119 |
| 100 | MP0010368_abnormal_lymphatic_system | 0.84980881 |
| 101 | MP0002896_abnormal_bone_mineralization | 0.83145210 |
| 102 | MP0008469_abnormal_protein_level | 0.82838580 |
| 103 | MP0003634_abnormal_glial_cell | 0.82749004 |
| 104 | MP0000733_abnormal_muscle_development | 0.82543084 |
| 105 | MP0000920_abnormal_myelination | 0.81588488 |
| 106 | MP0001851_eye_inflammation | 0.80864965 |
| 107 | MP0002971_abnormal_brown_adipose | 0.80697666 |
| 108 | MP0005623_abnormal_meninges_morphology | 0.80522332 |
| 109 | MP0003646_muscle_fatigue | 0.80400578 |
| 110 | MP0000750_abnormal_muscle_regeneration | 0.78708815 |
| 111 | MP0005166_decreased_susceptibility_to | 0.78694515 |
| 112 | MP0003866_abnormal_defecation | 0.78600974 |
| 113 | MP0005535_abnormal_body_temperature | 0.78543029 |
| 114 | MP0002138_abnormal_hepatobiliary_system | 0.78518763 |
| 115 | MP0002419_abnormal_innate_immunity | 0.77987726 |
| 116 | MP0001533_abnormal_skeleton_physiology | 0.77918327 |
| 117 | MP0002933_joint_inflammation | 0.77199833 |
| 118 | MP0003690_abnormal_glial_cell | 0.77157349 |
| 119 | MP0001845_abnormal_inflammatory_respons | 0.76968628 |
| 120 | MP0002723_abnormal_immune_serum | 0.76929157 |
| 121 | MP0002089_abnormal_postnatal_growth/wei | 0.76382258 |
| 122 | MP0005000_abnormal_immune_tolerance | 0.76212117 |
| 123 | MP0008569_lethality_at_weaning | 0.76168913 |
| 124 | MP0002398_abnormal_bone_marrow | 0.75870282 |
| 125 | MP0003633_abnormal_nervous_system | 0.75859181 |
| 126 | MP0002452_abnormal_antigen_presenting | 0.75136664 |
| 127 | MP0003656_abnormal_erythrocyte_physiolo | 0.75107574 |
| 128 | MP0005025_abnormal_response_to | 0.74901504 |
| 129 | MP0005334_abnormal_fat_pad | 0.74797844 |
| 130 | MP0010155_abnormal_intestine_physiology | 0.74363582 |
| 131 | MP0010630_abnormal_cardiac_muscle | 0.73776604 |
| 132 | MP0001765_abnormal_ion_homeostasis | 0.73195064 |
| 133 | MP0009333_abnormal_splenocyte_physiolog | 0.72551563 |
| 134 | MP0001756_abnormal_urination | 0.72019987 |
| 135 | MP0005164_abnormal_response_to | 0.71710149 |
| 136 | MP0005390_skeleton_phenotype | 0.71191541 |
| 137 | MP0001243_abnormal_dermal_layer | 0.71182558 |
| 138 | MP0005384_cellular_phenotype | 0.69804217 |
| 139 | MP0009785_altered_susceptibility_to | 0.69229020 |
| 140 | MP0003115_abnormal_respiratory_system | 0.69227387 |
| 141 | MP0000465_gastrointestinal_hemorrhage | 0.68943770 |
| 142 | MP0001614_abnormal_blood_vessel | 0.68868922 |
| 143 | MP0003795_abnormal_bone_structure | 0.67958274 |
| 144 | MP0002405_respiratory_system_inflammati | 0.67038199 |
| 145 | MP0001819_abnormal_immune_cell | 0.65439748 |
| 146 | MP0003448_altered_tumor_morphology | 0.65053843 |
| 147 | MP0002420_abnormal_adaptive_immunity | 0.64136950 |
| 148 | MP0002254_reproductive_system_inflammat | 0.63583409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 3.36343018 |
| 2 | Hyperacusis (HP:0010780) | 3.35317122 |
| 3 | Deep venous thrombosis (HP:0002625) | 3.14426774 |
| 4 | Vertebral compression fractures (HP:0002953) | 3.09163341 |
| 5 | Cerebral aneurysm (HP:0004944) | 2.86201111 |
| 6 | Flat acetabular roof (HP:0003180) | 2.77184615 |
| 7 | Abnormality of the lower motor neuron (HP:0002366) | 2.68614647 |
| 8 | Eczematoid dermatitis (HP:0000976) | 2.64748661 |
| 9 | Abnormality of the Achilles tendon (HP:0005109) | 2.57216114 |
| 10 | Insomnia (HP:0100785) | 2.54478259 |
| 11 | Xanthomatosis (HP:0000991) | 2.53680153 |
| 12 | Cholecystitis (HP:0001082) | 2.50792247 |
| 13 | Abnormal gallbladder physiology (HP:0012438) | 2.50792247 |
| 14 | Cervical subluxation (HP:0003308) | 2.50165989 |
| 15 | Achilles tendon contracture (HP:0001771) | 2.49331179 |
| 16 | Difficulty running (HP:0009046) | 2.46559436 |
| 17 | Asymmetric septal hypertrophy (HP:0001670) | 2.46456118 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 2.46124115 |
| 19 | Distal lower limb amyotrophy (HP:0008944) | 2.43061970 |
| 20 | Distal upper limb amyotrophy (HP:0007149) | 2.42371411 |
| 21 | Upper limb amyotrophy (HP:0009129) | 2.42371411 |
| 22 | Elfin facies (HP:0004428) | 2.38705043 |
| 23 | Supranuclear gaze palsy (HP:0000605) | 2.35854521 |
| 24 | Bundle branch block (HP:0011710) | 2.35726498 |
| 25 | Macroorchidism (HP:0000053) | 2.32198829 |
| 26 | Enlarged penis (HP:0000040) | 2.31284984 |
| 27 | Hand muscle atrophy (HP:0009130) | 2.30494331 |
| 28 | Complement deficiency (HP:0004431) | 2.30305637 |
| 29 | Neurofibrillary tangles (HP:0002185) | 2.29998726 |
| 30 | Broad metatarsal (HP:0001783) | 2.26399139 |
| 31 | Increased connective tissue (HP:0009025) | 2.26309555 |
| 32 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.25882054 |
| 33 | Broad face (HP:0000283) | 2.24669976 |
| 34 | Long toe (HP:0010511) | 2.20538468 |
| 35 | Peritonitis (HP:0002586) | 2.20430684 |
| 36 | Disproportionate tall stature (HP:0001519) | 2.19846600 |
| 37 | Back pain (HP:0003418) | 2.19545894 |
| 38 | Myoglobinuria (HP:0002913) | 2.15167448 |
| 39 | Shallow orbits (HP:0000586) | 2.14334194 |
| 40 | Renovascular hypertension (HP:0100817) | 2.13000519 |
| 41 | Myocardial infarction (HP:0001658) | 2.12601502 |
| 42 | Aneurysm (HP:0002617) | 2.11243967 |
| 43 | Bladder diverticulum (HP:0000015) | 2.10104434 |
| 44 | Ketosis (HP:0001946) | 2.07649785 |
| 45 | Frequent falls (HP:0002359) | 2.07109867 |
| 46 | Abnormality of macrophages (HP:0004311) | 2.07083476 |
| 47 | Difficulty climbing stairs (HP:0003551) | 2.06659430 |
| 48 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.05811263 |
| 49 | Abnormality of glycolipid metabolism (HP:0010969) | 2.05811263 |
| 50 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.05811263 |
| 51 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05563167 |
| 52 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05563167 |
| 53 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05563167 |
| 54 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.03863577 |
| 55 | Striae distensae (HP:0001065) | 2.03680903 |
| 56 | Overriding aorta (HP:0002623) | 2.03585960 |
| 57 | Polycythemia (HP:0001901) | 2.02953403 |
| 58 | Amyloidosis (HP:0011034) | 2.01466838 |
| 59 | Biconcave vertebral bodies (HP:0004586) | 2.00961985 |
| 60 | Exercise-induced myalgia (HP:0003738) | 2.00439982 |
| 61 | Turricephaly (HP:0000262) | 1.98352521 |
| 62 | Hemiplegia (HP:0002301) | 1.97039443 |
| 63 | Thin bony cortex (HP:0002753) | 1.96803520 |
| 64 | Protrusio acetabuli (HP:0003179) | 1.96039407 |
| 65 | Wormian bones (HP:0002645) | 1.95846968 |
| 66 | Mitral valve prolapse (HP:0001634) | 1.94913606 |
| 67 | Neuronal loss in central nervous system (HP:0002529) | 1.94321967 |
| 68 | Abnormality of carpal bone ossification (HP:0006257) | 1.94077729 |
| 69 | Abnormality of the common coagulation pathway (HP:0010990) | 1.93978170 |
| 70 | Lymphangioma (HP:0100764) | 1.93179150 |
| 71 | Global brain atrophy (HP:0002283) | 1.92529285 |
| 72 | Arterial tortuosity (HP:0005116) | 1.91590133 |
| 73 | Stridor (HP:0010307) | 1.91488808 |
| 74 | Loss of speech (HP:0002371) | 1.90284319 |
| 75 | Vascular tortuosity (HP:0004948) | 1.89340998 |
| 76 | Abnormal ossification of hand bones (HP:0005921) | 1.89233030 |
| 77 | Thoracic kyphosis (HP:0002942) | 1.89168520 |
| 78 | Atrophic scars (HP:0001075) | 1.88615184 |
| 79 | Ulnar bowing (HP:0003031) | 1.87404929 |
| 80 | Dilatation of the ascending aorta (HP:0005111) | 1.86874853 |
| 81 | Spinal rigidity (HP:0003306) | 1.86547364 |
| 82 | Blue sclerae (HP:0000592) | 1.85382680 |
| 83 | Mitral regurgitation (HP:0001653) | 1.84383901 |
| 84 | Interstitial pulmonary disease (HP:0006530) | 1.83953446 |
| 85 | Hyperlipoproteinemia (HP:0010980) | 1.83931708 |
| 86 | Atrioventricular block (HP:0001678) | 1.83335466 |
| 87 | Polygenic inheritance (HP:0010982) | 1.83318245 |
| 88 | Ketoacidosis (HP:0001993) | 1.82626188 |
| 89 | Long palpebral fissure (HP:0000637) | 1.81779059 |
| 90 | Dysostosis multiplex (HP:0000943) | 1.81628883 |
| 91 | Cellulitis (HP:0100658) | 1.81494454 |
| 92 | Bowel diverticulosis (HP:0005222) | 1.81107536 |
| 93 | Hematochezia (HP:0002573) | 1.80954144 |
| 94 | Dysmetric saccades (HP:0000641) | 1.80062669 |
| 95 | Pointed chin (HP:0000307) | 1.79273731 |
| 96 | Broad palm (HP:0001169) | 1.78520431 |
| 97 | Increased variability in muscle fiber diameter (HP:0003557) | 1.77974690 |
| 98 | Gout (HP:0001997) | 1.76863224 |
| 99 | Stroke (HP:0001297) | 1.76216974 |
| 100 | Distal lower limb muscle weakness (HP:0009053) | 1.75108322 |
| 101 | Cerebral inclusion bodies (HP:0100314) | 1.75000589 |
| 102 | Impaired social interactions (HP:0000735) | 1.74960447 |
| 103 | Abnormal social behavior (HP:0012433) | 1.74960447 |
| 104 | Abnormality of the acetabulum (HP:0003170) | 1.74823036 |
| 105 | Ankle clonus (HP:0011448) | 1.74679627 |
| 106 | Hammertoe (HP:0001765) | 1.73835402 |
| 107 | Type 1 muscle fiber predominance (HP:0003803) | 1.73715887 |
| 108 | Obstructive sleep apnea (HP:0002870) | 1.72354562 |
| 109 | Hyporeflexia of lower limbs (HP:0002600) | 1.72107261 |
| 110 | Hypoglycemic coma (HP:0001325) | 1.71688285 |
| 111 | Late onset (HP:0003584) | 1.71580161 |
| 112 | Aortic dissection (HP:0002647) | 1.70135585 |
| 113 | Metaphyseal cupping (HP:0003021) | 1.70127295 |
| 114 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.69778942 |
| 115 | Hypercortisolism (HP:0001578) | 1.69697780 |
| 116 | Amyotrophic lateral sclerosis (HP:0007354) | 1.69259042 |
| 117 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.69150353 |
| 118 | Peripheral hypomyelination (HP:0007182) | 1.68799546 |
| 119 | Reticulocytosis (HP:0001923) | 1.68625787 |
| 120 | Lower limb amyotrophy (HP:0007210) | 1.67868415 |
| 121 | Hyperammonemia (HP:0001987) | 1.67779802 |
| 122 | Mitral stenosis (HP:0001718) | 1.67637544 |
| 123 | Rapidly progressive (HP:0003678) | 1.67522345 |
| 124 | Neonatal onset (HP:0003623) | 1.67445638 |
| 125 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.67128478 |
| 126 | Abnormality of the thoracic spine (HP:0100711) | 1.66939010 |
| 127 | Visual hallucinations (HP:0002367) | 1.66920147 |
| 128 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.66568145 |
| 129 | T lymphocytopenia (HP:0005403) | 1.65742101 |
| 130 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.64629092 |
| 131 | Mucopolysacchariduria (HP:0008155) | 1.64629092 |
| 132 | Asymmetry of the thorax (HP:0001555) | 1.64469340 |
| 133 | Facial diplegia (HP:0001349) | 1.64080020 |
| 134 | Intrahepatic cholestasis (HP:0001406) | 1.64053782 |
| 135 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.64002517 |
| 136 | Fragile skin (HP:0001030) | 1.63982653 |
| 137 | Torticollis (HP:0000473) | 1.63166221 |
| 138 | Abnormality of the nasal mucosa (HP:0000433) | 1.63104919 |
| 139 | Abnormality of complement system (HP:0005339) | 1.63023324 |
| 140 | Resting tremor (HP:0002322) | 1.61339300 |
| 141 | Systemic lupus erythematosus (HP:0002725) | 1.61204547 |
| 142 | Sensorimotor neuropathy (HP:0007141) | 1.61103136 |
| 143 | Abnormality of the intrinsic pathway (HP:0010989) | 1.61080843 |
| 144 | Abnormality of the lumbar spine (HP:0100712) | 1.61030428 |
| 145 | Cardiomegaly (HP:0001640) | 1.60904767 |
| 146 | Depression (HP:0000716) | 1.60606693 |
| 147 | Spastic tetraparesis (HP:0001285) | 1.60532674 |
| 148 | Ankle contracture (HP:0006466) | 1.60343346 |
| 149 | Aortic aneurysm (HP:0004942) | 1.60207477 |
| 150 | Upper motor neuron abnormality (HP:0002127) | 1.60158169 |
| 151 | Coxa vara (HP:0002812) | 1.59765425 |
| 152 | Ulnar deviation of the wrist (HP:0003049) | 1.59705337 |
| 153 | Axonal loss (HP:0003447) | 1.59487633 |
| 154 | Hemorrhage of the eye (HP:0011885) | 1.59350493 |
| 155 | Hypercholesterolemia (HP:0003124) | 1.59233759 |
| 156 | Abnormality of the peritoneum (HP:0002585) | 1.58924068 |
| 157 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.57528136 |
| 158 | Apathy (HP:0000741) | 1.57081275 |
| 159 | Joint laxity (HP:0001388) | 1.54573200 |
| 160 | Increased IgE level (HP:0003212) | 1.54541322 |
| 161 | Short nail (HP:0001799) | 1.53866707 |
| 162 | Abnormality of oral frenula (HP:0000190) | 1.52087543 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.37067616 |
| 2 | PKN2 | 3.93771518 |
| 3 | PRPF4B | 3.12621219 |
| 4 | EEF2K | 3.04687634 |
| 5 | ERN1 | 3.03969380 |
| 6 | MAP3K10 | 2.45641903 |
| 7 | FGFR4 | 2.31489806 |
| 8 | CDK12 | 2.29203689 |
| 9 | PTK6 | 2.14882330 |
| 10 | SMG1 | 2.12759138 |
| 11 | TTN | 2.07843196 |
| 12 | RIPK1 | 1.98712096 |
| 13 | KSR2 | 1.89766746 |
| 14 | SIK1 | 1.86190783 |
| 15 | MAP4K1 | 1.75508112 |
| 16 | BCKDK | 1.74035033 |
| 17 | PRKD3 | 1.72025371 |
| 18 | EPHB1 | 1.61333948 |
| 19 | CAMKK1 | 1.57539290 |
| 20 | TYK2 | 1.53933731 |
| 21 | MAP3K9 | 1.47973775 |
| 22 | RET | 1.42925090 |
| 23 | TBK1 | 1.41910758 |
| 24 | TAOK1 | 1.40987563 |
| 25 | PRKCH | 1.39783386 |
| 26 | PDGFRA | 1.38699963 |
| 27 | ALK | 1.37144534 |
| 28 | LRRK2 | 1.35137832 |
| 29 | JAK1 | 1.30660351 |
| 30 | SCYL2 | 1.28133082 |
| 31 | MAP3K6 | 1.27039649 |
| 32 | MAP3K7 | 1.20725895 |
| 33 | TAOK2 | 1.19154679 |
| 34 | SIK2 | 1.18746646 |
| 35 | DDR2 | 1.14738704 |
| 36 | LMTK2 | 1.11546994 |
| 37 | ZAP70 | 1.09837893 |
| 38 | CAMK1G | 1.07878578 |
| 39 | MARK1 | 1.07393841 |
| 40 | IRAK3 | 1.07025718 |
| 41 | JAK3 | 1.06557112 |
| 42 | JAK2 | 1.04667404 |
| 43 | MAP3K3 | 1.03515789 |
| 44 | TYRO3 | 1.02239321 |
| 45 | CAMK1D | 1.00379114 |
| 46 | ARAF | 0.96526099 |
| 47 | EPHA2 | 0.95621097 |
| 48 | MAP3K11 | 0.95362139 |
| 49 | MAP3K14 | 0.95276930 |
| 50 | STK38 | 0.93733527 |
| 51 | SIK3 | 0.90563207 |
| 52 | PAK6 | 0.88406469 |
| 53 | FGFR3 | 0.87602227 |
| 54 | ICK | 0.87399163 |
| 55 | BMX | 0.83868750 |
| 56 | FGR | 0.83050965 |
| 57 | MAP2K3 | 0.81472976 |
| 58 | MAP3K2 | 0.81297845 |
| 59 | PHKG2 | 0.80063997 |
| 60 | PHKG1 | 0.80063997 |
| 61 | FLT3 | 0.79880162 |
| 62 | PDK1 | 0.79208967 |
| 63 | GRK6 | 0.78897070 |
| 64 | HCK | 0.78018894 |
| 65 | DAPK2 | 0.77635108 |
| 66 | MAP3K13 | 0.76084815 |
| 67 | KIT | 0.75641936 |
| 68 | PDGFRB | 0.74485913 |
| 69 | DYRK1B | 0.74345117 |
| 70 | IRAK4 | 0.72938692 |
| 71 | MAP3K1 | 0.72581724 |
| 72 | PDK4 | 0.71723497 |
| 73 | PDK3 | 0.71723497 |
| 74 | NEK9 | 0.71405521 |
| 75 | MTOR | 0.71008204 |
| 76 | CSF1R | 0.70933215 |
| 77 | PTK2 | 0.69097191 |
| 78 | RPS6KA2 | 0.68189463 |
| 79 | CAMKK2 | 0.66954573 |
| 80 | PAK4 | 0.66911528 |
| 81 | NME2 | 0.66902552 |
| 82 | PDPK1 | 0.62617391 |
| 83 | SGK3 | 0.62604346 |
| 84 | TESK2 | 0.62418612 |
| 85 | MARK2 | 0.62292722 |
| 86 | MOS | 0.61472903 |
| 87 | TGFBR2 | 0.61389709 |
| 88 | TAOK3 | 0.59562562 |
| 89 | DMPK | 0.58720648 |
| 90 | PRKD1 | 0.58608969 |
| 91 | MAPK12 | 0.58227089 |
| 92 | BLK | 0.58019937 |
| 93 | MST1R | 0.57729810 |
| 94 | PIM2 | 0.57344179 |
| 95 | FES | 0.57044987 |
| 96 | KSR1 | 0.56646106 |
| 97 | KDR | 0.56246368 |
| 98 | CDK6 | 0.56151208 |
| 99 | MAP2K4 | 0.55630591 |
| 100 | LATS2 | 0.55407196 |
| 101 | ITK | 0.54823337 |
| 102 | MAPK11 | 0.54252935 |
| 103 | NEK1 | 0.52716200 |
| 104 | CLK1 | 0.52641469 |
| 105 | MET | 0.52392437 |
| 106 | CDC42BPA | 0.51915234 |
| 107 | NTRK3 | 0.51461701 |
| 108 | LIMK1 | 0.51101371 |
| 109 | SYK | 0.50434403 |
| 110 | IKBKE | 0.48455957 |
| 111 | TESK1 | 0.48320759 |
| 112 | CSK | 0.47519193 |
| 113 | BTK | 0.46755886 |
| 114 | MAP3K8 | 0.46041816 |
| 115 | HIPK2 | 0.44732710 |
| 116 | EPHA3 | 0.44673492 |
| 117 | FGFR2 | 0.44538836 |
| 118 | RAF1 | 0.44386098 |
| 119 | MATK | 0.43755317 |
| 120 | RPS6KC1 | 0.43344923 |
| 121 | RPS6KL1 | 0.43344923 |
| 122 | PINK1 | 0.43138972 |
| 123 | PAK2 | 0.43102319 |
| 124 | MINK1 | 0.42659615 |
| 125 | BRD4 | 0.41514808 |
| 126 | RIPK4 | 0.40488121 |
| 127 | TGFBR1 | 0.39727052 |
| 128 | PRKD2 | 0.39092039 |
| 129 | MAP3K5 | 0.39061745 |
| 130 | FYN | 0.37273308 |
| 131 | NTRK1 | 0.36995989 |
| 132 | STK11 | 0.36876764 |
| 133 | IRAK2 | 0.36864498 |
| 134 | CDK11A | 0.36857168 |
| 135 | RPS6KA4 | 0.36825359 |
| 136 | CDK14 | 0.36508504 |
| 137 | CDK4 | 0.34255869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.68318059 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.19493001 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.02594836 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.72425105 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.90923136 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.88521452 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.84072142 |
| 8 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.66024374 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.60523990 |
| 10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.59990646 |
| 11 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.56732320 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.45743407 |
| 13 | Insulin resistance_Homo sapiens_hsa04931 | 1.40792169 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.39030255 |
| 15 | Bile secretion_Homo sapiens_hsa04976 | 1.35293455 |
| 16 | Shigellosis_Homo sapiens_hsa05131 | 1.31790318 |
| 17 | Bladder cancer_Homo sapiens_hsa05219 | 1.29703090 |
| 18 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.29259741 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.28942344 |
| 20 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.28519292 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.26048412 |
| 22 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.24626709 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.21193296 |
| 24 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.19463062 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.16519480 |
| 26 | Galactose metabolism_Homo sapiens_hsa00052 | 1.15275611 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.12630485 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.12546885 |
| 29 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.12435959 |
| 30 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.12424992 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.11219791 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11101622 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09134132 |
| 34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.08625975 |
| 35 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.06769131 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.06610417 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.05890310 |
| 38 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.04779793 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04515228 |
| 40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.01656195 |
| 41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.00817092 |
| 42 | Lysine degradation_Homo sapiens_hsa00310 | 1.00628677 |
| 43 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.99209868 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.98595980 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 0.98345936 |
| 46 | Adherens junction_Homo sapiens_hsa04520 | 0.97726104 |
| 47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.97219660 |
| 48 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.96951669 |
| 49 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.95541272 |
| 50 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.95034101 |
| 51 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.94316637 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.94123565 |
| 53 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.93637518 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.93186068 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.93184023 |
| 56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.93174269 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.92573366 |
| 58 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.91854964 |
| 59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91834123 |
| 60 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.91525254 |
| 61 | Lysosome_Homo sapiens_hsa04142 | 0.91501330 |
| 62 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.91261959 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.91006407 |
| 64 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.90421323 |
| 65 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.89901129 |
| 66 | Thyroid cancer_Homo sapiens_hsa05216 | 0.89579859 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.88936855 |
| 68 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.88098557 |
| 69 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.87695245 |
| 70 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86473459 |
| 71 | Influenza A_Homo sapiens_hsa05164 | 0.86267357 |
| 72 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.85787448 |
| 73 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.84320759 |
| 74 | Apoptosis_Homo sapiens_hsa04210 | 0.84109879 |
| 75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83040413 |
| 76 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.82596552 |
| 77 | Tuberculosis_Homo sapiens_hsa05152 | 0.82443928 |
| 78 | Leishmaniasis_Homo sapiens_hsa05140 | 0.81992435 |
| 79 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.81476922 |
| 80 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.80426336 |
| 81 | Glioma_Homo sapiens_hsa05214 | 0.79542361 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.78957198 |
| 83 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.78766838 |
| 84 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.78646396 |
| 85 | Phagosome_Homo sapiens_hsa04145 | 0.78390017 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77861063 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77728729 |
| 88 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77702492 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.77316481 |
| 90 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.76644603 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.76523478 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75960508 |
| 93 | Platelet activation_Homo sapiens_hsa04611 | 0.74720300 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.73095553 |
| 95 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72993389 |
| 96 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.72383737 |
| 97 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.71420684 |
| 98 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.71233664 |
| 99 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70001103 |
| 100 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.69804384 |
| 101 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69795228 |
| 102 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.69251125 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69188499 |
| 104 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68575900 |
| 105 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67835059 |
| 106 | Amoebiasis_Homo sapiens_hsa05146 | 0.67393019 |
| 107 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67349607 |
| 108 | Malaria_Homo sapiens_hsa05144 | 0.67342909 |
| 109 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67330156 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66792619 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.65765606 |
| 112 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.65724425 |
| 113 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.65444617 |
| 114 | Measles_Homo sapiens_hsa05162 | 0.65088374 |
| 115 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64648542 |
| 116 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64096730 |
| 117 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.63461581 |
| 118 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.61502827 |
| 119 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.60696465 |
| 120 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60473397 |
| 121 | Prostate cancer_Homo sapiens_hsa05215 | 0.60155089 |
| 122 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.60021006 |
| 123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59898990 |
| 124 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59399198 |
| 125 | Insulin secretion_Homo sapiens_hsa04911 | 0.58759099 |
| 126 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58535231 |
| 127 | Legionellosis_Homo sapiens_hsa05134 | 0.58046297 |
| 128 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57682582 |
| 129 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56852143 |
| 130 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55685447 |
| 131 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.55166921 |
| 132 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54154999 |
| 133 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.54144503 |
| 134 | Focal adhesion_Homo sapiens_hsa04510 | 0.53343249 |
| 135 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.53158243 |
| 136 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51298193 |
| 137 | Viral myocarditis_Homo sapiens_hsa05416 | 0.49021898 |
| 138 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48935654 |
| 139 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48004109 |
| 140 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47995932 |
| 141 | Long-term potentiation_Homo sapiens_hsa04720 | 0.45214855 |
| 142 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.44764683 |

